Kamada (KMDA) Revenue Growth (5y) (2017 - 2026)
Kamada (KMDA) Revenue Growth (5y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 89.60 Bn | 87.73 Bn | - |
| 2 | Teva Pharmaceutical Industries | 35.83 Bn | 32.09 Bn | 1.97 Bn |
| 3 | Zoetis | 32.46 Bn | 30.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 27.56 Bn | 23.49 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn |
| 6 | RedHill Biopharma | 21.48 Bn | 21.48 Bn | - |
| 7 | Viatris | 20.28 Bn | 18.48 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.78 Bn | 16.46 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.61 Bn | 12.18 Bn | 785.00 Mn |
| 10 | Kamada | 402.37 Mn | 329.22 Mn | 19.12 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 12.68% |
| Dec 31, 2025 | 7.21% |
| Sep 30, 2025 | 5.88% |
| Jun 30, 2025 | 322.89% |
| Mar 31, 2025 | 5.75% |
| Dec 31, 2024 | 3.99% |
| Sep 30, 2024 | 4.77% |
| Jun 30, 2024 | 313.22% |
| Mar 31, 2024 | 7.09% |
| Dec 31, 2023 | -5.45% |
| Sep 30, 2023 | 20.43% |
| Jun 30, 2023 | 2.04% |
| Mar 31, 2023 | 345.80% |
| Dec 31, 2022 | 4.94% |
| Sep 30, 2022 | 243.76% |
| Jun 30, 2022 | -11.80% |
| Mar 31, 2022 | 19.25% |
| Dec 31, 2021 | 5.34% |
| Sep 30, 2021 | -15.43% |
| Jun 30, 2021 | -6.47% |